MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617075417 A) filed by Lanova Medicines Limited on June 18, 2026, for Anp-Dependent Antibodies.
Inventors include Li, Runsheng; Shi, Lei; and Zang, Ying Qin.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Provided are antibodies capable of binding an antigen in an adenine nucleotide-dependent manner. Examples of adenine nucleotides include ATP, ADP and AMP, which are frequently present in tumor microenvironment at much higher concentrations in normal tissues. Such antibodies, if designed to target a tumor associated antigen or immune checkpoint molecule, can target tumor tissues more specifically than conventionally antibodies and thus have improved therapeutic index.
Disclaimer: Curated by HT Syndication.
